PACLITERO 260MG INJ
  • PACLITERO 260MG INJ
PACLITERO 260MG INJ

PACLITERO 260MG INJ

Vendor: PACLITERO
Availability: In stock
Product type: Oncology
Composition: PACLITAXEL
Strength: 260MG
Dosage Form: Injection

Prescription Required
₹ 1,500.00 MRP: ₹ 9,815.63 85% OFF
Inclusive of all taxes.
PACLITERO 260MG INJ
₹ 1,500.00
₹ 9,815.63 ₹ 1,500.00 (-85%)
Strength: 260MG
Dosage Form: Injection
PACLITERO 260MG INJ
PACLITERO 260MG INJ
₹ 1,500.00 MRP: ₹ 9,815.63 85% OFF

Introduction

Paclitero 260mg Injection contains paclitaxel, a taxane anticancer medicine that prevents cancer cell division by stabilising microtubules.

Uses

Paclitero 260mg Injection is used for the treatment of various cancers.

  • Breast cancer
  • Ovarian cancer
  • Non-small cell lung cancer
  • Kaposi's sarcoma

Storage

  • Store below 25°C.
  • Protect from light.
  • Do not freeze.

Safety Information

  • Blood counts should be monitored regularly.
  • Premedication may be required to reduce hypersensitivity reactions.

Possible Side Effects

Possible side effects may include:

  • Hair loss
  • Nausea
  • Peripheral neuropathy
  • Low blood cell counts
  • Muscle pain
  • Infusion reactions

About RareMeds

We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.

The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.

No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.

Disclaimer

Paclitero is a prescription anticancer medicine.

It should only be administered under the supervision of a qualified oncologist.

Related Products